Research Article
Association of IGF-1 CA(n) and IGFBP3 rs2854746 Polymorphisms with Endometrial Polyp Risk
Table 2
Characterization of the sample for IGF-1 genotyping.
| | Control | Polyp | O.R | 95 C.I. | P-Value |
| | Grouping 1 | | | | | |
| | CA(19)/CA(19) | 19 (23%) | 34 (33%) | | | |
| | CA(19)/CA(n) | 44 (54%) | 49 (47%) | | | 0,382 |
| | CA(n)/CA(n) | 18 (22%)
| 21 (20%)
| | | |
| | Grouping 2 | | | | | |
| | CA(19)/CA(19) | 19 (23%) | 34 (33%) | 2,57 | (1,09-6,01) | 0,024 |
| | CA(19)/CA(<19) + CA(<19)/CA(<19) | 23 (28%) | 16 (15%) | 1 | | |
| | CA(>19)/CA(n) | 39 (48%) | 54 (52%) | 1,99 | (0,93-4,25) | 0,076 |
| | Grouping 3 | | | | | |
| | CA(19)/CA(<19) + CA(<19)/CA(<19) | 23 (28%) | 16 (15%) | 1 | | |
| | CA(19)/CA(19) + CA(>19)/CA(n) | 58 (72%) | 88 (85%) | 2,18 | (1,06-4,47) | 0,033 |
| | Total | 81 | 104 | |
| |
|
|
A: alanine.
C: cysteine.
CA: allele cysteine-alanine.
|
